Notification from "Donev investments holding" AD under Art. 19 of Regulation (EU) No 596/2014 of 6 June 2022.
Treasury shares
Sofia, Bulgaria, December 4, 2023 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on December 1, 2023 the Company bought 66 000 own shares representing 0.0382% of the share capital of the Company, at a total value of BGN 469 600 on the Bulgarian Stock Exchange, the average price per share was BGN 7,12.
Sales revenues for May 2022
Sofia, Bulgaria, June 6, 2022 – According to the requirements of art. 100t of LPOS, “Sopharma” AD notifies that for May 2022 the Company recorded an increase in sales of 16% compared to the same month of the previous year, incl. 24% decrease in domestic sales and 77% increase in export sales.
For the five months since the beginning of the year the revenues from sales of products increase by 28%, incl. 35% increase of sales for the domestic market and 24% increase in export sales.
Notification from "Donev investments holding" AD under Art. 19 of Regulation (EU) No 596/2014 of 3 June 2022.
Notification under Art. 111 para. 6 of LPOS for repurchase of shares
Sofia, Bulgaria, June 3, 2022 – According to the requirements of Art. 100t of LPOS, “Sopharma” AD notifies that on the basis of Art. 187b of the Commercial Law and Art. 111 para. 5 and para.
Notification from "Donev investments holding" AD under Art. 19 of Regulation (EU) No 596/2014 of 1 June 2022.
Skonsolidowane sprawozdanie finansowe wg MSSF na dzień 31 marca 2022 r. - Excel
Oświadczenie odpowiedzialnych dyrektorów na dzień 31 marca 2022 r.
Informacja zgodnie z załącznikiem nr 4 na dzień 31 marca 2022 r.
Strony
- « pierwsza
- ‹ poprzednia
- …
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- …
- następna ›
- ostatnia »